Expression of RPL4 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL4 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 612.31

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

691.5

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	2424.8
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	2337.3
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	1769.5
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1628.3
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1366.9
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1236.6
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1211.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	1107.1
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1038.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1032.7
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	992.6
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	983.4
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	966.6
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	959.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	937.0
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	935.7
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	911.0
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	886.3
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	881.8
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	879.4
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	877.6
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	868.6
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	864.0
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	857.1
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	850.6
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	850.0
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	833.0
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	831.5
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	827.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	815.8
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	814.6
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	807.9
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	790.2
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	786.2
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	782.6
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	778.8
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	777.6
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	761.8
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	761.3
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	761.0
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	759.5
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	754.6
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	749.6
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	743.9
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	743.0
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	739.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	732.7
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	729.1
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	722.9
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	716.5
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	712.8
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	712.1
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	712.1
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	702.8
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	696.4
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	693.8
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	693.4
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	690.8
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	683.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	676.8
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	675.1
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	674.5
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	671.5
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	669.0
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	664.7
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	663.0
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	662.7
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	661.5
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	656.4
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	652.2
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	644.3
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	642.5
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	641.3
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	640.3
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	639.2
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	635.7
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	635.6
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	620.8
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	616.5
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	613.4
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	612.3
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	605.7
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	597.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	597.0
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	587.9
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	587.8
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	587.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	586.0
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	581.3
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	577.4
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	576.1
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	574.8
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	572.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	569.6
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	563.3
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	562.0
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	557.9
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	556.7
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	549.3
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	529.1
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	527.2
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	525.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	522.2
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	520.3
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	518.3
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	512.4
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	510.3
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	502.5
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	501.3
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	495.3
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	494.5
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	494.4
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	491.2
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	483.6
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	478.7
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	462.4
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	460.6
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	460.0
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	449.9
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	448.4
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	446.8
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	444.1
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	443.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	439.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	432.4
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	428.5
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	417.8
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	414.9
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	412.9
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	407.0
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	404.0
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	384.5
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	377.0
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	354.4
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	349.0
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	344.6
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	343.3
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	326.8
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	315.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	291.0
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	204.0
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL4 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 533.27

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

672.9

Number of samples

Samples

Sample	Description	pTPM
AK066	N, NA, stage:NA, alive, 960 days	2161.8
AK142	N, NA, stage:NA, alive, 90 days	1349.3
AK043	N, NA, stage:NA, alive, 660 days	1137.2
AK124	N, NA, stage:NA, alive, 1920 days	1120.2
AK231	N, NA, stage:NA, dead, 240 days	994.5
AK213	N, NA, stage:NA, alive, 2010 days	956.6
AK165	N, NA, stage:NA, alive, 360 days	904.7
AK199	N, NA, stage:NA, alive, 1860 days	883.1
AK133	N, NA, stage:NA, dead, 360 days	836.4
AK139	N, NA, stage:NA, dead, 270 days	834.5
AK002	N, NA, stage:NA, dead, 570 days	831.4
AK055	N, NA, stage:NA, dead, 240 days	810.2
AK102	N, NA, stage:NA, alive, 1740 days	774.9
AK041	N, NA, stage:NA, alive, 810 days	774.9
AK098	N, NA, stage:NA, dead, 660 days	759.9
AK185	N, NA, stage:NA, alive, 330 days	752.6
AK072	N, NA, stage:NA, dead, 150 days	751.0
AK074	N, NA, stage:NA, alive, 300 days	707.9
AK003	N, NA, stage:NA, dead, 600 days	701.3
AK195	N, NA, stage:NA, dead, 390 days	674.4
AK173	N, NA, stage:NA, dead, 180 days	668.8
AK088	N, NA, stage:NA, dead, 360 days	664.7
AK188	N, NA, stage:NA, alive, 420 days	663.7
AK178	N, NA, stage:NA, dead, 240 days	657.2
AK068	N, NA, stage:NA, alive, 360 days	640.2
AK149	N, NA, stage:NA, dead, 420 days	631.4
AK071	N, NA, stage:NA, dead, 540 days	630.4
AK236	N, NA, stage:NA, dead, 360 days	627.0
AK156	N, NA, stage:NA, dead, 330 days	624.4
AK015	N, NA, stage:NA, alive, 720 days	617.7
AK134	N, NA, stage:NA, dead, 360 days	605.0
AK205	N, NA, stage:NA, dead, 120 days	603.1
AK158	N, NA, stage:NA, dead, 360 days	597.9
AK153	N, NA, stage:NA, dead, 240 days	579.9
AK183	N, NA, stage:NA, alive, 360 days	575.4
AK030	N, NA, stage:NA, dead, 120 days	568.2
AK085	N, NA, stage:NA, alive, 660 days	566.1
AK100	N, NA, stage:NA, alive, 960 days	554.3
AK049	N, NA, stage:NA, dead, 180 days	554.1
AK216	N, NA, stage:NA, dead, 360 days	536.8
AK103	N, NA, stage:NA, alive, 1320 days	535.9
AK167	N, NA, stage:NA, dead, 180 days	530.6
AK051	N, NA, stage:NA, dead, 360 days	524.6
AK089	N, NA, stage:NA, dead, 330 days	507.0
AK227	N, NA, stage:NA, alive, 300 days	493.4
AK035	N, NA, stage:NA, dead, 210 days	485.2
AK218	N, NA, stage:NA, dead, 180 days	484.8
AK076	N, NA, stage:NA, alive, 660 days	472.2
AK079	N, NA, stage:NA, dead, 210 days	464.3
AK053	N, NA, stage:NA, dead, 300 days	458.2
AK081	N, NA, stage:NA, dead, 180 days	456.6
AK117	N, NA, stage:NA, dead, 210 days	445.7
AK123	N, NA, stage:NA, dead, 180 days	426.2
AK091	N, NA, stage:NA, dead, 210 days	425.2
AK226	N, NA, stage:NA, dead, 360 days	395.5
AK005	N, NA, stage:NA, dead, 240 days	360.6
AK099	N, NA, stage:NA, dead, 420 days	355.5
AK006	N, NA, stage:NA, dead, 360 days	324.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0182580003	Tumor	1.0
CPT0206560003	Tumor	1.0
CPT0218690004	Tumor	0.8
CPT0127480003	Tumor	0.8
CPT0206230003	Tumor	0.7
CPT0205450004	Tumor	0.7
CPT0190360004	Tumor	0.7
CPT0218330004	Tumor	0.6
CPT0224390004	Tumor	0.6
CPT0224540004	Tumor	0.6
CPT0125510003	Tumor	0.6
CPT0217710008	Tumor	0.5
CPT0228220003	Tumor	0.5
CPT0205780003	Tumor	0.5
CPT0189750004	Tumor	0.5
CPT0218830004	Tumor	0.5
CPT0078580003	Tumor	0.4
CPT0167640003	Tumor	0.4
CPT0208980003	Tumor	0.4
CPT0205570003	Tumor	0.4
CPT0206000004	Tumor	0.4
CPT0219080004	Tumor	0.4
CPT0093510003	Tumor	0.4
CPT0093360003	Tumor	0.4
CPT0162020003	Tumor	0.3
CPT0087950003	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0168380003	Tumor	0.3
CPT0225760003	Tumor	0.3
CPT0221180003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0206880003	Tumor	0.3
CPT0182500003	Tumor	0.3
CPT0162100003	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0225730003	Tumor	0.3
CPT0217000004	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0125570003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0168080003	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0161730003	Tumor	0.2
CPT0167530003	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0064890003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0087570003	Tumor	0.1
CPT0087730003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0206450003	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0093450003	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0217430008	Tumor	0.0
CPT0217880003	Tumor	0.0
CPT0206670004	Tumor	0.0
CPT0123530003	Tumor	0.0
CPT0189850004	Tumor	0.0
CPT0182550003	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0071100003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0171580008	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0167970003	Tumor	-0.1
CPT0196850003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0201710003	Tumor	-0.2
CPT0093590003	Tumor	-0.2
CPT0207090003	Tumor	-0.2
CPT0167750004	Tumor	-0.3
CPT0168480003	Tumor	-0.3
CPT0168720003	Tumor	-0.3
CPT0167860004	Tumor	-0.4
CPT0087680003	Tumor	-0.4
CPT0218960004	Tumor	-0.5
CPT0092440003	Tumor	-0.5
CPT0189250003	Tumor	-0.5
CPT0104220003	Tumor	-0.5
CPT0218670003	Tumor	-0.5
CPT0209440003	Tumor	-0.5
CPT0207030003	Tumor	-0.6
CPT0104330003	Tumor	-0.6
CPT0218770003	Tumor	-0.7
CPT0204380003	Normal	-0.7
CPT0204360003	Normal	-0.8
CPT0199770003	Tumor	-0.8
CPT0204340003	Normal	-0.8
CPT0224330003	Tumor	-0.8
CPT0204410003	Normal	-0.9
CPT0162140003	Tumor	-1.0
CPT0190240004	Tumor	-1.0
CPT0204390003	Normal	-1.0
CPT0206330003	Tumor	-1.0
CPT0204350003	Normal	-1.0
CPT0204420003	Normal	-1.1
CPT0204400003	Normal	-1.1
CPT0204370003	Normal	-1.2
CPT0204330003	Normal	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA034600
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade
Glioma, malignant, High grade Glioblastoma, NOS